📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cavion

1.1 - Company Overview

Cavion Logo

Cavion

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage therapies targeting T-type calcium channels (Cav3) for cancer and neurologic diseases, including CX-8998, a modulator in Phase 2 for essential tremor and absence epilepsy, and Mibefradil, a partially selective blocker tested with hypofractionated radiation in recurrent glioblastoma multiforme.

Products and services

  • Cav3-Selective Drug Development Program: Engineers mechanism-specific therapies that selectively inhibit T-type calcium channels (Cav3) for neurologic diseases and solid tumor cancers, leveraging ion channel targeting for treatment
  • CX-8998: A clinical-phase T-type calcium channel (Cav3) modulator investigated in Phase 2 trials for essential tremor and absence epilepsy
  • Mibefradil: A combination-therapy, partially selective T-type calcium channel blocker tested with hypofractionated radiation therapy for recurrent glioblastoma multiforme

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cavion

Bioinduction Logo

Bioinduction

HQ: United Kingdom Website
  • Description: Provider of faster and simpler deep brain stimulation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bioinduction company profile →
Kineta Logo

Kineta

HQ: United States Website
  • Description: Provider of biotechnology drug discovery focused on diseases caused by protein misfolding, offering immunotherapies such as KVA12123, a VISTA-blocking agent in Phase 1/2 trials as monotherapy and with pembrolizumab, and an anti-CD27 agonist mAb to activate T and NK cells and address exhausted T cells in the tumor microenvironment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kineta company profile →
Iama Therapeutics Logo

Iama Therapeutics

HQ: Italy Website
  • Description: Provider of novel neuroscience therapeutics for pediatric brain disorders, advancing drug discovery to address unmet needs; lead candidate IAMA-6 is an orally administered small molecule targeting NKCC1-associated neuronal hyperexcitability, currently in Phase 1 clinical trials for autism and epilepsy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Iama Therapeutics company profile →
Javelin Pharmaceuticals Logo

Javelin Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceutical research, development, and commercialization of products for the pain management market primarily in the United States and Europe, focusing on treatments for various pain disorders ranging from acute and episodic moderate-to-severe pain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Javelin Pharmaceuticals company profile →
Bonti Logo

Bonti

HQ: United States Website
  • Description: Provider of biotechnology, based in Orange, California. Founded in 2015 by Fauad Hasan, Mike Jarpe, Susan Abushakra, and Wajdie Ahmad.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bonti company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cavion

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cavion

2.2 - Growth funds investing in similar companies to Cavion

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cavion

4.2 - Public trading comparable groups for Cavion

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cavion

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cavion

What does Cavion do?

Cavion is a provider of clinical-stage therapies targeting T-type calcium channels (Cav3) for cancer and neurologic diseases, including CX-8998, a modulator in Phase 2 for essential tremor and absence epilepsy, and Mibefradil, a partially selective blocker tested with hypofractionated radiation in recurrent glioblastoma multiforme.

Who are Cavion's competitors?

Cavion's competitors and similar companies include Bioinduction, Kineta, Iama Therapeutics, Javelin Pharmaceuticals, and Bonti.

Where is Cavion headquartered?

Cavion is headquartered in United States.

How many employees does Cavion have?

Cavion has 1,000 employees 🔒.

When was Cavion founded?

Cavion was founded in 2010 🔒.

What sector and industry vertical is Cavion in?

Cavion is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cavion

Who are the top strategic acquirers in Cavion's sector and industry

Top strategic M&A buyers and acquirers in Cavion's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cavion?

Top strategic M&A buyers groups and sectors for Cavion include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cavion's sector and industry vertical

Which are the top PE firms investing in Cavion's sector and industry vertical?

Top PE firms investing in Cavion's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cavion's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cavion's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cavion's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cavion include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cavion's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cavion?

The key public trading comparables and valuation benchmarks for Cavion include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cavion for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cavion with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cavion's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cavion with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cavion's' sector and industry vertical?

Access recent funding rounds and capital raises in Cavion's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cavion

Launch login modal Launch register modal